Klavdia Levina

974 total citations
9 papers, 508 citations indexed

About

Klavdia Levina is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Klavdia Levina has authored 9 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Klavdia Levina's work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (5 papers) and Diagnosis and treatment of tuberculosis (4 papers). Klavdia Levina is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (5 papers) and Diagnosis and treatment of tuberculosis (4 papers). Klavdia Levina collaborates with scholars based in Estonia, Sweden and Russia. Klavdia Levina's co-authors include Annika Krüüner, Manfred Danilovitš, Solomon Ghebremichael, Sven Hoffner, Gunilla Källenius, Heinart Sillastu, Andra Cīrule, Davide Manissero, Vaira Leimane and Charles D. Wells and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Klavdia Levina

8 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klavdia Levina Estonia	5	470	395	222	77	33	9	508
Ģirts Šķenders Latvia	12	510 1.1×	467 1.2×	204 0.9×	86 1.1×	36 1.1×	22	573
R Lepe Chile	2	345 0.7×	265 0.7×	133 0.6×	83 1.1×	36 1.1×	4	431
A. Koul United States	4	370 0.8×	303 0.8×	101 0.5×	142 1.8×	52 1.6×	6	445
Navisha Dookie South Africa	9	316 0.7×	249 0.6×	102 0.5×	110 1.4×	31 0.9×	13	409
Zhaojing Zong China	10	332 0.7×	278 0.7×	86 0.4×	127 1.6×	47 1.4×	17	398
K. J. M. Aung Bangladesh	11	704 1.5×	639 1.6×	259 1.2×	95 1.2×	62 1.9×	20	741
Tiina Kummik Estonia	6	355 0.8×	321 0.8×	127 0.6×	67 0.9×	17 0.5×	7	402
Lea Pehme Estonia	8	374 0.8×	264 0.7×	152 0.7×	74 1.0×	8 0.2×	10	420
Aung Kya Jai Maug Belgium	7	518 1.1×	423 1.1×	189 0.9×	70 0.9×	34 1.0×	9	550
Jason Limberis United States	12	398 0.8×	291 0.7×	149 0.7×	94 1.2×	15 0.5×	17	477

Countries citing papers authored by Klavdia Levina

Since Specialization

Citations

This map shows the geographic impact of Klavdia Levina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klavdia Levina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klavdia Levina more than expected).

Fields of papers citing papers by Klavdia Levina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klavdia Levina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klavdia Levina. The network helps show where Klavdia Levina may publish in the future.

Co-authorship network of co-authors of Klavdia Levina

This figure shows the co-authorship network connecting the top 25 collaborators of Klavdia Levina. A scholar is included among the top collaborators of Klavdia Levina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klavdia Levina. Klavdia Levina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Vyazovaya, Anna, et al.. (2020). Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster. Tuberculosis. 1602–1602.

2.

Mokrousov, Igor, et al.. (2020). Spatiotemporal dynamics of drug‐resistant Mycobacterium tuberculosis : Contrasting trends and implications for tuberculosis control in EU high‐priority country. Transboundary and Emerging Diseases. 68(2). 896–906. 2 indexed citations

3.

Vyazovaya, Anna, et al.. (2017). Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context. Journal of Antimicrobial Chemotherapy. 73(2). 325–331. 3 indexed citations

4.

Danilovitš, Manfred, Lea Pehme, Ģirts Šķenders, et al.. (2012). Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis. European Respiratory Journal. 41(6). 1393–1400. 233 indexed citations

5.

Krüüner, Annika, Pontus Juréen, Klavdia Levina, Solomon Ghebremichael, & Sven Hoffner. (2003). Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 47(9). 2971–2973. 65 indexed citations

6.

Lockman, Shahin, Annika Krüüner, Nancy Binkin, et al.. (2001). Clinical Outcomes of Estonian Patients with Primary Multidrug-Resistant versus Drug-Susceptible Tuberculosis. Clinical Infectious Diseases. 32(3). 373–380. 31 indexed citations

7.

Krüüner, Annika, Sven Hoffner, Heinart Sillastu, et al.. (2001). Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia. Journal of Clinical Microbiology. 39(9). 3339–3345. 153 indexed citations

8.

Kubín, M, et al.. (1999). Present state of tuberculosis in the Czech Republic and in central European and Baltic countries.. PubMed. 7(3). 109–15. 3 indexed citations

9.

Krüüner, Annika, et al.. (1998). Drug resistant tuberculosis in Estonia.. PubMed. 2(2). 130–3. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact